Skip to content
★ Sign in to follow
RC

RootK Co., Ltd. Stock: price and insider trades · South Korea

에이비프로바이오

KR·Mcap ₩16.1BIndustrials

No insider purchase over the last 90 days. The latest, by 리턴즈, was filed 08 Apr 2026.

RootK Co., Ltd.: what insiders have been doing

RootK Co., Ltd. belongs to the Industrials sector. Filings by its managers are published through DART (FSS). Over the twelve months to 2 November 2026, 9 filings were filed, from 2 insiders.

Every open-market trade in the period is a purchase: 2 purchases worth €2.3M, from 1 insider, and not a single sale. The totals exclude 1 filing filed without an amount. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. 리턴즈 filed the largest purchase, €2.3M, on 8 April 2026, which represents 17.3% of the company's market value.

With 9 filings in twelve months, the company is more active than the median of 7 filings across the 2,655 companies we follow on the same exchange. Our records for RootK Co., Ltd. go back to 2021, with 34 purchases and 1 sale on the open market in total.

The last insider purchase was made public on 8 April 2026, 216 days ago.

Other companies in the same sector with recent insider buying flagged by our signals: Auroora Yhtiöt Oyj and MBB SE. Source: insider filings from DART (FSS). Past trades are no guide to future returns.

Insider Decl.
53
Thresholds
n/a
Buy Volume
€630M
34 ops. · all time
Sell Volume
n/a
1 ops. · all time

Who traded when

BuySale
리턴즈2 buys

Since the insiders bought

  • Filed 08 Apr 2026 · 216 days ago · €2.3M
    -49.7%
    Entry ₩1,368 · Close at T+90 ₩688
  • Filed 26 Dec 2023 · 1050 days ago · €44.0M
    -27.6%
    Entry ₩5,370 · Close at T+365 ₩3,890

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Financial data

as of FY 2025

FY ended December 2025 · cache

₩988
Analyst consensus
·
Income statement
Revenue₩31.9B
Gross profit₩3.5B11% margin
EBITDA-₩46.3B-145% margin
Net income-₩48.9B-16.4% margin
Valuation
Beta-0.20
Balance sheet & cash
Market cap₩16.1B
Total debt₩15.5B
Free Cash Flow-₩9B
Debt / Equity35%
Profitability & ownership
ROE-8.9%
ROA-7.5%
% insiders12.6%
% institutions0.0%
Last declaration on 27 May 2026
Declarations53 total
  • ●
    Executives
    Executives(filed)
    0DART
  • ●
    Executives
    Executives(filed)
    0DART
  • ▲
    -Executives
    4B KRW10DART
    4,106,776 shares@ ₩974.0017.27% mcap100.0% of flowShareKRXDART:20260408002599
    Canonical exit: 30 Jun 2026 (T+90)
  • ▲
    Executives
    0DART
    4,106,776 sharesKRXDART:20260408002604
    Canonical exit: 30 Jun 2026 (T+90)
  • ●
    Executives
    Executives(filed)
    0DART
  • ●
    Executives
    Executives(filed)
    0DART
  • ●
    Executives
    Executives(filed)
    0DART
  • ●
    Executives
    Executives(filed)
    0DART
  • ●
    Executives
    Executives(filed)
    0DART
  • ●
    Executives
    Executives
    0DART
  • ●
    Executives
    Executives
    0DART
  • ▲
    Related company / holdingExecutives
    €36.6Mest.0DART
    11,695,904 sharesKRXDART:20240624000230
    Canonical exit: 15 Sept 2024 (T+90)
  • ●
    Executives
    Executives(filed)
    0DART
  • ▼
    Related company / holdingExecutives
    0DART
    903,706 sharesShareKRXDART:20240412003594
  • ●
    Executives
    Executives(filed)
    0DART
  • ▲
    Related company / holdingExecutives
    €44.0Mest.0DART
    11,695,904 sharesKRXDART:20231226000481
    Canonical exit: 25 Mar 2024 (T+90)
  • ▲
    Related company / holdingExecutives
    €50.3Mest.0DART
    11,695,904 sharesKRXDART:20231020000505
    Canonical exit: 13 Jan 2024 (T+90)
  • ▲
    Related company / holdingExecutives
    €44.1Mest.0DART
    11,695,904 sharesKRXDART:20230926000617
    Canonical exit: 25 Dec 2023 (T+90)
  • ▲
    Related company / holdingExecutives
    €33.2Mest.0DART
    11,695,904 sharesKRXDART:20230626000404
    Canonical exit: 24 Sept 2023 (T+90)
  • ▲
    -Executives
    0DART
    ShareKRXDART:20230512001150
    Canonical exit: 2 Aug 2023 (T+90)
  • ▲
    Related company / holdingExecutives
    0DART
    11,695,904 sharesKRXDART:20230512001165
    Canonical exit: 2 Aug 2023 (T+90)
  • ▲
    -Executives(filed)
    0DART
    ShareKRXDART:20230503000650
    Canonical exit: 1 Aug 2023 (T+90)
  • ▲
    Related company / holdingExecutives
    0DART
    11,695,904 sharesKRXDART:20230503000653
    Canonical exit: 24 Jul 2023 (T+90)
  • ▲
    Related company / holdingExecutives
    €42.3Mest.0DART
    11,695,904 sharesKRXDART:20230424000529
    Canonical exit: 23 Jul 2023 (T+90)
  • ▲
    -Executives(filed)
    0DART
    ShareKRXDART:20230330001489
    Canonical exit: 28 Jun 2023 (T+90)

25 of 53 declarations

About RootK Co., Ltd.

Established in the industrial sector, 에이비프로바이오 is a company listed on the XKRX market. It specializes in the development of biopharmaceutical products.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations